Mo1738 COLORECTAL ENDOSCOPIC SUBMUCOSAL DISSECTION FOR DYSPLASIA AND SUPERFICIAL NEOPLASMS IN INFLAMMATORY BOWEL DISEASE: A MULTICENTER STUDY FROM NORTH AMERICA

Patients with inflammatory bowel disease (IBD) have an increased risk of colorectal dysplasia and cancer. Endoscopically visible lesions with distinct borders and without features of submucosal (SM) invasion should be considered for endoscopic resection. En bloc resection is preferred for these lesions because it allows for precise histologic evaluation. However, it is often not feasible due to the high prevalence of SM fibrosis, particularly for large lesions ( ≥2 cm). Endoscopic submucosal dissection (ESD) has been proposed as one of the therapeutic options for these lesions; however, outcomes data are restricted to a few small studies and are scant from North America.

Source: Gastrointestinal Endoscopy - May 31, 2020 Category: Gastroenterology Authors: Saowanee Ngamruengphong, Hiroyuki Aihara, Makoto Nishimura, David M. Faleck, Shai Friedland, Petros C. Benias, Dennis Yang, Peter V. Draganov, Nikhil A. Kumta, Zachary A. Borman, Rebekah E. Dixon, James F. Marion, Lionel D'Souza, Yutaka Tomizawa, Sonmoon Tags: Poster abstracts Source Type: research